KESJEMO
"KESJEMO" is a word mark owned by Glaxo Group Limited, filed at the USPTO on October 6, 2026. It is under examination and covers class 5 (Pharmaceuticals).
- Status
- Under examination
- Since October 6, 2026
- Filed
- October 6, 2026
- Registered
- Not yet
- Expires
- Not recorded
- Application no.
- 50146287
- Registration no.
- Not yet
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word mark
- 1 class
Who owns KESJEMO
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Glaxo Group Limited
Stevenage, United Kingdom
Representative
Christopher M. Hanes
GSK
What the mark covers
The products and services KESJEMO is filed for, grouped by Nice class.
Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; Pharmaceutical preparations for the prevention of infectious diseases; Vaccines; Anti-infectives
What has happened so far
Steps recorded by the USPTO, newest first.
- Application filing receipt mailed
- New application office supplied data entered
- New application entered
About KESJEMO
Who owns the trademark "KESJEMO"?
The USPTO trademark "KESJEMO" (application 50146287) is owned by Glaxo Group Limited.
What is the status of "KESJEMO"?
Its status at the USPTO is: under examination.
Get this data via the API
Everything on this page comes from the Signa API. Pull KESJEMO and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_01a11679-adec-76c8-9529-3a6536ee46f7
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_01a11679-adec-76c8-9529-3a6536ee46f7",
"object": "trademark",
"mark_text": "KESJEMO",
"status": {
"primary": "pending",
"stage": "examining"
},
"office_code": "US",
"application_number": "50146287",
"filing_date": "2026-10-06",
"nice_classes": [
5
],
"owners": [
{
"name": "Glaxo Group Limited",
"entity_id": "ent_019eb6f6-4cb9-77ae-916f-63b3231a6d3d"
}
]
}